C M Bidwell & Associates LTD Supernus Pharmaceuticals, Inc. Transaction History

C M Bidwell & Associates LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$27.57 - $32.91 $87,838 - $104,851	-3,186 Reduced 98.12%	61 $1,000
Q2 2023 Aug 11, 2023	SELL	$29.91 - $38.73 $27,965 - $36,212	-935 Reduced 22.36%	3,247 $97,000
Q1 2023 May 11, 2023	BUY	$34.93 - $42.03 $146,077 - $175,769	4,182 New	4,182 $151,000
Q2 2022 Aug 12, 2022	SELL	$25.33 - $34.25 $74,014 - $100,078	-2,922 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$28.51 - $32.9 $41,196 - $47,540	1,445 Added 97.83%	2,922 $94,000
Q4 2021 Feb 11, 2022	BUY	$26.37 - $34.22 $38,948 - $50,542	1,477 New	1,477 $43,000
Q2 2021 Aug 13, 2021	SELL	$26.72 - $33.19 $206,412 - $256,392	-7,725 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$24.15 - $31.45 $184,143 - $239,806	7,625 Added 7625.0%	7,725 $202,000
Q4 2020 Feb 16, 2021	BUY	$17.7 - $25.81 $1,770 - $2,581	100 New	100 $3,000
Q3 2020 Nov 13, 2020	SELL	$20.2 - $25.05 $55,348 - $68,637	-2,740 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$17.09 - $24.89 $46,826 - $68,198	2,740 New	2,740 $65,000
Q3 2018 Nov 13, 2018	SELL	$42.7 - $56.55 $41,419 - $54,853	-970 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$44.1 - $59.85 $42,777 - $58,054	970 New	970 $58,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.